BritaMed, Inc.   Report issue

For profit
Founded: Richmond BC Canada (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2018
NCT02019446
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

terbinafine (lamisil) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1